Romero-Masters, J. C., Huebner, S. M., Ohashi, M., Bristol, J. A., Benner, B. E., Barlow, E. A., . . . Kenney, S. C. (2020). B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. PLoS Pathog.
Styl ChicagoRomero-Masters, James C., et al. "B Cells Infected With Type 2 Epstein-Barr Virus (EBV) Have Increased NFATc1/NFATc2 Activity and Enhanced Lytic Gene Expression in Comparison to Type 1 EBV Infection." PLoS Pathog 2020.
Citace podle MLARomero-Masters, James C., et al. "B Cells Infected With Type 2 Epstein-Barr Virus (EBV) Have Increased NFATc1/NFATc2 Activity and Enhanced Lytic Gene Expression in Comparison to Type 1 EBV Infection." PLoS Pathog 2020.